Year: 2026
Type: article
Abstract: Introduction The aryl hydrocarbon receptor (AHR), initially characterized as a sensor of environmental toxicants, is now recognized as an important regulator of innate immunity and macrophage biology. Although AHR has been shown to influence macrophage polarization and the differentiation of human monocytes into monocyte-derived macrophages or dendritic cells, the molecular and metabolic mechanisms underlying AHR activation in primary human macrophages remain poorly characterized. This study aimed to investigate the effects of AHR activation on the functional, transcriptional, and metabolic profiles of human monocyte-derived macrophages. Methods Human monocyte-derived macrophages were treated with the xenobiotic AHR ligand 6-formylindolo[3,2-b]carbazole (FICZ). An integrative approach combining functional assays, transcriptomic profiling, and targeted metabolomics was used to characterize the effects of AHR activation. Results FICZ treatment increased cytosolic reactive oxygen species (ROS) production, mitochondrial mass, and basal respiration, while significantly reducing phagocytosis. Transcriptomic analyses revealed coordinated changes in pathways associated with immune regulation and cellular metabolism. Targeted metabolomics further identified metabolic alterations consistent with AHR-mediated cellular reprogramming. Discussion These findings provide an integrated characterization of the functional, transcriptional, and metabolic responses induced by AHR activation in human monocyte-derived macrophages. They offer new insights into the role of AHR in regulating macrophage immunometabolism and function.
Source: Frontiers in Immunology
Authors: Carlota Alvarez-Lucena(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing), Hengxin Huang(Data curation, Formal analysis, Visualization, Writing – review & editing), Rodrigo Landauro-Vera(Investigation, Methodology, Writing – review & editing), Marta Cascante(Data curation, Formal analysis, Software, Supervision, Visualization, Writing – review & editing), Lucía Fernández-Frías(Investigation, Methodology, Writing – review & editing), Sergio Madurga(Data curation, Formal analysis, Software, Supervision, Visualization, Writing – review & editing), Carmen Delgado(Funding acquisition, Project administration, Supervision, Writing – review & editing), Silvia Marin(Data curation, Formal analysis, Software, Supervision, Visualization, Writing – review & editing), Lisardo Boscá(Conceptualization, Data curation, Funding acquisition, Investigation, Project administration, Resources, Supervision, Visualization, Writing – review & editing), Adrián Povo-Retana(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Visualization, Writing – original draft, Writing – review & editing)
Institutions: Consejo Superior de Investigaciones Científicas, Instituto de Salud Carlos III, Instituto de Investigaciones Biomédicas Sols-Morreale, Centro de Investigación en Red en Enfermedades Cardiovasculares, Institut de Biomedicina de la Universitat de Barcelona, Universitat de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Universidad Francisco de Vitoria
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7235878636
